This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:


peer-reviewed publication

trusted source


Engineer discovers method to improve pharmaceuticals through dolphin research

Engineer discovers method to improve pharmaceuticals through dolphin research
Structure and morphology of NH4HU crystals. a, b SEM images of rod-like NH4HU crystals prepared at pH 11 and 12 mM urate. The inset of panel b shows the end face of crystals with a hexagonal cross-section. c Schematic diagram of indexed NH4HU crystal facets. d Typical 3D reconstructed reciprocal lattice of a single NH4HU crystal viewed along the b-axis. The crystal facets could be indexed from the 3D ED data, as shown in panel c. e 2D (h0l) slice cut from the reconstructed 3D reciprocal lattice of NH4HU showing reflection condition h0l: h = 2n and l = 2n. f Pawley profile fitting (red line) of the powder XRD pattern (black dots) with difference plot (green line) of NH4HU crystals. The black tick marks at the bottom represent the positions of Bragg reflections. Inset: Molecular structure of NH4HU showing ionization at the nitrogen (N3) site. g Microfluidics measurements of macroscopic growth rates along the b-direction, r<010>, at pH 11 (control, gray squares) and pH 7 (red diamonds) as a function of urate concentration. Data are the average measurements of 10 to 15 crystals and error bars span two standard deviations. Dashed lines are interpolated to serve as a guide to the eye. The gray- and green-shaded regions distinguish growth regimes in pH 7 solutions. h, i SEM images of NH4HU crystals prepared at pH 7 and 6–7 mM urate. j TEM image showing the straight segment of a bent NH4HU crystal. Inset: Corresponding SAED pattern revealing the growth orientation along the <010> direction. Scale bar equals 5 nm−1. k SEM image of a crystal prepared at pH 7 and 14 mM urate with a dumbbell-shaped morphology. l Filtered TEM image as determined by a low-dose (4 e2) fractionation technique showing the atomic clusters of the structure (dots in the image) with enlarged images of dashed boxes in panel l showing the absence (m) and presence (n) of defects. Credit: Nature Communications (2023). DOI: 10.1038/s41467-023-35924-3

In the body, crystals—made of things such as calcium or a collection of urine—form masses that can cause pain and serious health conditions. A University of Houston crystals expert, Jeffrey Rimer, Abraham E. Dukler Professor of Chemical Engineering, known globally for his seminal breakthroughs using innovative methods to control crystals to help treat malaria and kidney stones, is reporting a new method to control the growth of ammonium urate crystals, the substance known to cause kidney stones in dolphins.

Yes, dolphins get , too. And how did we find this out? You can thank the Navy.

In fact, move over Navy SEAL—the is another marine mammal working hard defending our shores. With their highly evolved ability to detect objects, the dolphins have been helping the U.S. Navy find underwater mines for decades as part of the U.S. Navy Marine Mammal Program.

As part of that program, the Navy takes good care of its dolphin friends, driving research on such matters as dolphin kidney stones. Rimer has been riding the wave of dolphin research for a while, previously reporting on crystals associated with dolphin kidney stones made of ammonium urate, rarely found in humans.

Now he's leading an international team of researchers from Tianjin University China, Stockholm University Sweden, University of Pittsburgh, University of Strathclyde, Glasgow Scotland, Texas A&M University, Purdue University, Instituto Politecnico Nacional Mexico and The Molecular Foundry at Lawrence Berkeley National Laboratory.

On behalf of the team, Rimer has published new work in Nature Communications on their discovery of a method to control the of ammonium urate by manipulating isomers of urate called tautomers. The findings may not only help dolphins but may also have implications for the pharmaceutical industry.

"We found that a small fraction of urate existing as a minor tautomer can control the rate at which crystals grow to the point they can completely block crystallization," said Rimer. "It was the most unexpected and remarkable thing to find that as you increase the concentration of urate, all of a sudden the rate of crystallization drops to almost zero and crystals do not grow in that region."

Rimer thinks it may be possible to mimic those results by diet control to get the concentration in the kidney in that range, so then the possibility exists that crystal growth would be inhibited, and medicine would be unnecessary.

That goes for dolphins and humans, alike, but more on that in future research.

Examining urate crystals, Rimer also found that tautomers get incorporated into crystals as defects, and that is where the findings have implications for pharmaceuticals.

Among the top 200 drugs, there are 33 (including allopurinol, used to treat stones) that are tautomers. These medications impact millions worldwide, prescribed for HIV, epilepsy, COVID-19, schizophrenia and cancer (skin, lung and pancreatic).

"When we produced crystals with very few defects, they dissolved much slower whereas with a higher percentage of defects dissolve faster," said Rimer. "That is critical for pharmaceuticals because when you put medicine into your body, their effectiveness is related to how fast they dissolve," said Rimer.

"We are asking the question about these 33 pharmaceuticals—do companies really know the extent to which they develop defects? The same question can be posed for nature where tautomers may impact in species that are vital to their intended function like in fish or color change in chameleons," he said.

With Rimer's continued research, these questions may soon be answered.

More information: Weiwei Tang et al, Tautomerism unveils a self-inhibition mechanism of crystallization, Nature Communications (2023). DOI: 10.1038/s41467-023-35924-3

Journal information: Nature Communications

Citation: Engineer discovers method to improve pharmaceuticals through dolphin research (2023, February 3) retrieved 17 April 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Does zinc inhibit or promote growth of kidney stones? Well, both


Feedback to editors